Brentwood Associates sells its stake in Wendy Bennison-led SAXX Underwear to TZP Group
From our Women's PE Briefs - week commencing August 30, 2021
Brentwood Associates sells its stake in Wendy Bennison-led SAXX Underwear to TZP Group
SAXX Underwear Co., Ltd., a men’s underwear brand whose CEO is Wendy Bennison, has a new private equity owner. Brentwood Associates has sold its stake in the Vancouver, B.C. company to TZP Group. Terms were not disclosed, but NLS Group Holdings, which has been an investor in SAXX since 2010, will retain a significant minority interest. Brentwood backed SAXX in December 2016.
Founded in 2006, SAAX has grown its business to include comfortable, premium, high-performance men’s apparel tailored to support an active lifestyle. It has more than 5,800 retailer partners globally.
Wendy joined SAXX as CEO in 2017 after being president of Kit and Ace. Her background also includes serving as president and chief operating officer of Roots and holding a series of leadership roles with Mark’s Work Wearhouse, a division of Canadian Tire, Inc.
Erika Wasser's Prospr raises $3.2M from Bonfire Ventures, Quiet Capital and ANIMO Ventures
A frontline, deskless workforce management platform co-founded by Erika Wasser garners capital to improve the future of work. Prospr received $3.2 million of fresh capital led by Bonfire Ventures and joined by Quiet Capital and ANIMO Ventures.
New York-based Prospr offers robust real-time communication, learning and development, scheduling, shift management, task and facilities ticketing and more. Fully customizable, Prospr works for every type of team, but focuses on when frontline employees are customer-facing and quality of work and information sharing is key.
In a statement, Erika said, “we’re able to build better software for operators and employees because everyone on our team has been there. I’ve been an hourly worker, I’ve been a manager, and the owner/operator. We’re a software that powers businesses with a lot of moving parts, big goals and vulnerable workforces, the success of all parties in that ecosystem is our priority and we’re excited to keep building.” With this raise, Prospr is poised to provide small to medium-sized business and enterprise with employee management tools, most specifically for multi-location or franchise businesses with customer facing frontline employees.
Livingbridge invests in Melissa Chapman-led Jungle Creations
A private equity firm puts capital into a London-based social media publishing company co-led by Melissa Chapman. The amount raised by Jungle Creations from Livingbridge was not disclosed.
Jungle Creations creates, produces and distributes content across seven media brands focused on interest areas including food and drink, arts and crafts and female lifestyle. The company’s content is primarily distributed through social media platforms including Facebook, Snapchat, TikTok, Instagram and YouTube. Livingbridge’s investment will support Jungle in fueling its growth strategy, including the launch of new brands, increased content output for existing brands and internationalization.
Hila Goldman-Aslan’s DiA Imaging Analysis raises $14M
An Israeli provider of AI-based solutions for ultrasound analysis co-founded by Hila Goldman-Aslan scans in fresh capital. DiA Imaging Analysis raised $14 million in funding from XTX Ventures, Downing Ventures, Philips, Alchimia Investments, ICON Community Fund and existing investors CE Ventures, Connecticut Innovations, DEFTA Partners, Mindset Ventures and Shmuel Cabilly.
DiA Imaging’s AI-based technology imitates the way the human eye detects borders and identifies motion, allowing clinicians of all levels of experience to capture the right ultrasound images and automatically identify clinical abnormalities that are otherwise difficult to find visually. The company intends to use the funds to expand its portfolio of solutions, pursue new and expanded partnerships with ultrasound vendors, PACS/health care IT companies, resellers and distributors, as well as grow its global presence in Asia, Europe and the U.S.
Marta Margolis’ Atheneum closes on $150M in funding
Investors put significant capital behind a German company co-founded by Marta Margolis that has created a platform for conducting virtual surveys and interviews. Atheneum closed on $150 million in funding from Guidepost Growth Equity, unnamed limited partners and such existing investors as Crosslantic Capital Management, Michael Brehm and Vogel Communications Group, according to TechCrunch.
Atheneum provides a platform for companies to conduct and analyze research sourced through virtual interviews and surveys with stakeholders. The company plans to use the funds to continue expanding geographically, hiring more people for its team and building out its technology.
Sarah Sheehan's Bravely raises $15M in a round led by Telescope Partners
A platform co-founded by Sarah Sheehan connecting people to on-demand professional coaching and development lands additional funding. Bravely raised $15 million in a round led by Telescope Partners with participation from prior investors Primary Venture Partners, Bling Capital, Correlation Ventures, RiverPark Ventures, Tuesday Capital, as well as new investor SemperVirens Venture Capital.
Bravely, a New York-based coaching platform, has also previously received capital from TMV, which was founded Soraya Darabi and Marina Hadjipateras. Bravely is designed to scale whole-population support for companies of all sizes and boasts a coaching network in the industry.
With this funding round, Bravely will both expand its global reach and develop powerful new data capabilities, allowing for an even deeper understanding of, and capacity to serve, diverse individual employee needs. In addition to new automation and personalization, this capital will also power research informing Bravely’s ethical, inclusion-focused use of data, as well as developing a people science function at the company.
Andrea Mazzocchi and Katie-Rose Skelly’s Known Medicine raises $7.2M
A company co-founded by Andrea Mazzocchi and Katie-Rose Skelly focused on creating the best drug for every cancer patient lands funding. Known Medicine raised $7.2 million from Caffeinated Capital, Khosla Ventures, Cota Capital, Kickstart, Forward VC, OATV, Y Combinator and several angel investors.
Based in Salt Lake City, Known Medicine’s custom micro-tumor platform utilizes novel bioengineering methods, bringing together biology research and the newest AI techniques. Its Oncology Diagnostics Inference Network platform uses proprietary organoid models and a bespoke image analysis pipeline to predict how well a patient’s tumor will respond to a specific treatment method before it is prescribed. This funding will enable Known Medicine to rapidly grow its proprietary 3-D cell culture data set for deployment in partnership with biopharmaceutical companies and in the clinical diagnostics space.
In a statement, Andrea said, “oncologists and patients, particularly late-stage cancer patients, need every tool we can give them to make the best treatment decisions. Our ODIN platform is designed to provide rapid, actionable data to assist in that difficult process.” Katie-Rose added in a statement, “our core technology and data first approach will provide critical technical, biological and clinical insights to drug developers and prescribers across the continuum from bench to bedside.”
Rachel Zhang’s Omnillion raises $25M in Series A funding
A Canadian cloud and global data network for app developers co-founded by Rachel Zhang secures capital. Omnillion raised $25 million in Series A funding. The investors in this round are not disclosed.
Based in Toronto, Omnillion is a technology company that aims to empower every developer and organization to achieve more in their business through edge computing. The company will use the funding to develop more features; integrate with content delivery networks, cloud and telecom providers; and expand its engineering teams in the U.S., Eastern Europe and India. It also plans to open new data centers globally in Ukraine, Taiwan, Ireland, Mexico and Argentina.
George Kenley’s Seer Medical raises 34M Australian dollars in Series A funding
An Australian epilepsy diagnostics service co-founded by George Kenley secures funding to help patients diagnose and monitor their condition from home. Seer Medical raised 34 million Australian dollars in Series A funding from Cochlear, EWM Group, SG Hiscock and Giant Leap, according to Startup Daily.
Seer is creating technology for the diagnosis and management of neurological conditions, with a special focus on epilepsy. Seer’s technology is focused on clinical monitoring at home, developing devices checking key physiological signals, such as brain, heart and respiratory function, along with a person’s behavior in their home environment, to deal with conditions such as epilepsy diagnostics and management.
The funding will be used to expand Seer’s diagnostic services offering to target the sleep and cardiac market more directly, as well as further development of its devices, cloud computing infrastructure and machine learning capabilities. The company also wants to expand its product and service offerings to the U.S., U.K. and Europe.
Snejina Zacharia’s Insurify raises $100M in Series B funding
Snejina Zacharia’s effort to simplify shopping for car insurance gets a sizable boost. Insurify, which Snejina co-founded and serves as CEO of, raised $100 million in Series B funding from Motive Partners, Viola Growth, Fort Ross Ventures and existing investors Viola FinTech, MassMutual Ventures, Nationwide, Hearst Ventures and Moneta VC.
Based in Cambridge, Mass., Insurify is an online marketplace that uses predictive modeling and advanced analytics to reinvent the experience of shopping for car insurance. Snejina founded the company in 2013. She previously was director of business development at Gartner.